» Articles » PMID: 9337145

Adriamycin Cardiomyopathy: Pathophysiology and Prevention

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 1997 Oct 23
PMID 9337145
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Current knowledge about adriamycin cardiomyopathy indicates that the major cause of this condition is increased oxidative stress although the drug's antitumor action in patients may involve other mechanisms. Controversies about the different antioxidants in preventing cardiomyopathy likely stem from the fact that antioxidants must be effective in both the lipid and water phases, and the dose must be optimal, in order to be protective. Probucol, an antioxidant and promoter of endogenous antioxidants, is one such agent. Conducting clinical trials with an optimal dose of probucol is the next step and should make this great anticancer drug safer and more efficient in the fight against the cancer.

Citing Articles

In Vitro Effects of Some Chemotherapeutics on Human Erythrocyte Glucose-6-Phosphate Dehydrogenase Enzyme.

Coban C, Temel Y, Ciftci M ACS Omega. 2024; 9(49):48292-48298.

PMID: 39676939 PMC: 11635681. DOI: 10.1021/acsomega.4c06155.


Circulating Biomarkers for Monitoring Chemotherapy-Induced Cardiotoxicity in Children.

Meo L, Savarese M, Munno C, Mirabelli P, Ragno P, Leone O Pharmaceutics. 2023; 15(12).

PMID: 38140053 PMC: 10747387. DOI: 10.3390/pharmaceutics15122712.


Yang-xin-xue keli exerts therapeutic effects regulating mitochondrial homeostasis and function in doxorubicin-induced rat heart failure.

Long K, Zhao Z, Chen J, Zhi L, Wang C, Liao D Front Pharmacol. 2022; 13:931453.

PMID: 36110548 PMC: 9468485. DOI: 10.3389/fphar.2022.931453.


Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational study.

Nakayama T, Oshima Y, Kusumoto S, Yamamoto J, Osaga S, Fujinami H EJHaem. 2022; 1(2):498-506.

PMID: 35845008 PMC: 9176145. DOI: 10.1002/jha2.110.


RARG S427L attenuates the DNA repair response to doxorubicin in induced pluripotent stem cell-derived cardiomyocytes.

Huang H, Christidi E, Shafaattalab S, Davis M, Tibbits G, Brunham L Stem Cell Reports. 2022; 17(4):756-765.

PMID: 35364012 PMC: 9023798. DOI: 10.1016/j.stemcr.2022.03.002.